Daraprim News

SACRAMENTO, Calif. (AP)–A company once owned by “Pharma Bro” Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4,000% after obtaining exclusive rights to the drug, …

A Blue Cross Blue Shield affiliate sued “Pharma Bro” Martin Shkreli, the pharmaceutical industry’s imprisoned enfant terrible, in a Manhattan federal court Thursday, alleging a scheme to monopolize the market for Daraprim, the “gold-standard treatment” for the parasitic infection toxoplasmosis. …